Loading...
XNAS
NOTV
Market cap474kUSD
Jul 09, Last price  
0.02USD
1D
38.24%
1Q
-91.79%
Jan 2017
-97.56%
Name

Bioanalytical Systems Inc

Chart & Performance

D1W1MN
XNAS:NOTV chart
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
24.50%
Rev. gr., 5y
53.36%
Revenues
513m
+4.54%
43,047,67545,245,00041,697,00031,784,00028,781,00033,144,00028,208,00022,068,00024,584,00022,698,00020,441,00024,242,00026,346,00043,616,00060,469,00089,605,000547,656,000572,425,000490,739,000513,024,000
Net income
-69m
L-36.72%
-2,609,942926,000-1,489,000-5,463,000-2,691,000543,000-6,390,000773,000-1,070,0001,089,000-3,230,000884,000-194,000-790,000-4,685,00010,895,000-337,262,000-105,140,000-108,445,000-68,625,000
CFO
-10m
L+53.64%
3,843,9292,928,000598,0002,587,0002,441,0001,088,000-200,0001,519,0001,684,0002,031,0001,060,0001,236,0003,487,0001,777,0001,290,00010,746,000-5,217,00027,883,000-6,805,000-10,455,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
URL
https://www.inotivco.com/
IPO date
Nov 25, 1997
Employees
2,099
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT